Medically reviewed by Dr. Irvine Russell M.D. (UCI) · Updated April 2026

Kratom safety — interactions, contraindications, and harm reduction.

Direct answer

Kratom acts as an atypical opioid and stimulant. It carries significant risks of poly-substance toxicity and inhibits CYP3A4 and CYP2D6 metabolism, which can raise blood levels of many prescription drugs to dangerous levels. Never combine kratom with opioids, benzodiazepines, alcohol, or MAOIs.

Do not combine with opioids

Combining kratom with opioids (oxycodone, fentanyl, morphine, heroin) produces additive CNS depression. Both substances act on mu-opioid receptors — the result is profound respiratory depression and a sharply elevated risk of fatal overdose. Mitragynine also inhibits CYP3A4, which can push opioid blood levels into toxic ranges.

Do not combine with benzodiazepines

Benzodiazepines (Xanax, Valium, Klonopin) and kratom both suppress autonomic function. Kratom's stimulant component can mask initial sedation, but the combined metabolic load often causes delayed respiratory failure during sleep. This combination is a leading factor in kratom-involved hospitalizations.

Do not combine with alcohol

Ethanol and kratom create an additive hepatic burden. Alcohol amplifies the "wobbles" (dizziness, nystagmus) associated with higher kratom doses and slows alkaloid clearance. Severe nausea and vomiting while sedated carries aspiration risk. Long-term combined use is associated with hepatic impairment.

Do not combine with MAOIs

MAOIs (phenelzine, selegiline, linezolid) interact dangerously with kratom's indole alkaloids. Kratom increases norepinephrine and serotonin release; blocking their breakdown with an MAOI can trigger hypertensive crisis or serotonin syndrome — medical emergencies with risk of multi-organ failure.

Drug-interaction reference

12 known interactions · Sorted by severity

Drug / Class Severity Mechanism Recommendation
Opioids (oxycodone, fentanyl, morphine) Severe Additive CNS & respiratory depression Avoid entirely
Benzodiazepines (Xanax, Valium, Klonopin) Severe Additive sedation → respiratory failure Avoid entirely
Alcohol (ethanol) Severe Additive sedation + hepatotoxicity Do not combine
Tramadol Severe Lowered seizure threshold Dangerous — avoid
MAOIs (phenelzine, selegiline) Severe Hypertensive crisis / serotonin syndrome Avoid entirely
SSRIs / SNRIs Moderate Serotonin syndrome risk Consult physician
CYP3A4 inhibitors (grapefruit, ketoconazole) Moderate Increased kratom alkaloid levels Reduce kratom amount
CYP2D6 inhibitors (fluoxetine, paroxetine) Moderate Slowed kratom metabolism Consult physician
Stimulants / Adderall Moderate Cardiovascular strain, anxiety Use caution
Gabapentin / Pregabalin Moderate Additive CNS depression, blackout risk Use caution
Cannabis Minor Additive sedation Monitor effects
Caffeine Minor Additive stimulation, increased anxiety Monitor anxiety

Pregnancy & neonatal risk

Kratom during pregnancy causes Neonatal Abstinence Syndrome

Newborns exposed to mitragynine in utero frequently require hospitalization and medical detoxification for withdrawal — tremors, irritability, feeding difficulties, and respiratory distress have been documented. The CDC has reported multiple cases. If you are pregnant or nursing, discontinue use and consult a physician.

Seek emergency care if you experience:

Seizures or sudden tremors
Extreme difficulty breathing
Severe chest pain or palpitations
Uncontrollable vomiting
Yellowing of skin or eyes (jaundice)
Suicidal thoughts or severe psychosis

FDA enforcement · July 2025

Alert: isolated 7-hydroxymitragynine (7-OH) products

The FDA issued warning letters in July 2025 to firms marketing isolated 7-OH products (tablets, tinctures, shots). Unlike whole-leaf kratom, high-potency 7-OH concentrates have significantly higher mu-opioid receptor affinity and a dramatically increased risk of physical dependency and overdose. See our FDA enforcement timeline for context.

Tolerance & dependence

Daily kratom use leads to tolerance within 1–2 weeks. Withdrawal typically starts 12–24 hours after the last dose and peaks around days 2–4 with muscle aches, insomnia, restless legs, anxiety, and diarrhea. Symptoms generally resolve in 7–10 days. Dependency is real but is not considered life-threatening for leaf kratom alone (unlike alcohol or benzo withdrawal).

Harm-reduction taper

  1. 01

    Establish your baseline daily gram total on a digital scale.

  2. 02

    Reduce daily intake by 0.5g every 3–5 days.

  3. 03

    Spread your remaining amount over 3–4 small doses to avoid peak/trough swings.

  4. 04

    Use OTC loperamide (for GI symptoms), ibuprofen, and hydration to manage withdrawal.

Safety FAQ

Is kratom safe?
Safety depends on dose, purity, frequency, and individual health. Pure kratom from AKA-GMP certified vendors is used by millions, but the risk of dependency and severe drug interactions (especially with CNS depressants) is real. Fatalities almost always involve polysubstance use.
Can you overdose on kratom?
Kratom-only fatalities are rare but documented. Most kratom-related deaths involve combinations with opioids, benzodiazepines, alcohol, or fentanyl contamination. High-dose 7-hydroxymitragynine concentrates carry significantly higher overdose risk than leaf kratom.
What are signs of kratom addiction?
Physical dependence signs: needing kratom to sleep, "brain fog" without it, escalating dose for the same effect, withdrawal 12–24 hours after last use (muscle aches, restless legs, insomnia, diarrhea). Behavioral signs: neglected responsibilities, hiding use, failed attempts to stop.
How do I quit kratom?
Taper slowly — reduce daily intake by 0.5g every 3–5 days. Abrupt cessation is uncomfortable but not medically dangerous for leaf kratom alone. For 7-OH products or if combining with other substances, seek medical supervision. SAMHSA (1-800-662-4357) can refer you to treatment.
Is kratom detected on drug tests?
Standard 5-panel and 10-panel employment drug tests do NOT detect mitragynine. Specialized kratom-specific panels (used by some pain clinics and probation) can detect alkaloids for up to 7–14 days after last use.

Crisis resources

SAMHSA Helpline

1-800-662-4357

24/7 · Free · Confidential

Poison Control

1-800-222-1222

24/7 US nationwide

American Kratom Association

americankratom.org

Vendor verification, legislative tracker

This site does not provide medical advice. All content is for informational and harm-reduction purposes. Always consult a licensed medical professional before starting, stopping, or changing any substance use.

Harm reduction

Kratom pharmacology and dependence risk explained.

Read safety guide →